Ukraine confirms first case of new COVID-19 'Cicada' subvariant

The subvariant was first identified globally in November 2024 in South Africa. It was named after the insect known for lying dormant underground for years — a nod to the virus's prolonged period of low activity before it began spreading more widely.

"Based on reports from other countries, the clinical presentation of the disease caused by the Cicada subvariant does not differ significantly from other COVID-19 variants," said Deputy Health Minister and Chief State Sanitary Doctor Ihor Kuzin.

The World Health Organization (WHO) currently assesses that Cicada does not show signs of elevated risk or large-scale disease waves. However, health officials stress that the subvariant requires ongoing epidemiological surveillance at the national level.

In Ukraine, the Ministry said samples are collected at hospitals and sent to regional Centers for Disease Control and Prevention. Samples that test positive for COVID-19 are then forwarded to the Public Health Center laboratory for further analysis.

Symptoms of the Cicada subvariant are similar to those of other COVID-19 strains and include runny nose, fever, cough, headache, fatigue, loss of smell or taste, and possible eye irritation and rashes.

The Ministry emphasized that vaccination remains the primary protection against severe illness and complications. Ukraine is currently using an Omicron-specific vaccine for this purpose.

Health officials recommend booster shots every six to 12 months for the following groups:

• Adults and children with weakened immune systems or underlying health conditions
• Pregnant women
• People over 60
• Adults and children at higher risk of severe COVID-19
• Healthcare workers, teachers, soldiers, and others with elevated exposure risk

Anyone experiencing symptoms is advised to consult a doctor, who will determine whether a booster shot is needed based on Ministry-approved guidelines.